Molecular basis of Pirh2-mediated p53 ubiquitylation

被引:87
|
作者
Sheng, Yi [1 ,2 ,4 ]
Laister, Rob C. [1 ,2 ]
Lemak, Alexander [1 ,2 ]
Wu, Bin [1 ,2 ]
Tai, Elizabeth [1 ,2 ]
Duan, Shili [1 ,2 ]
Lukin, Jonathan [1 ,2 ]
Sunnerhagen, Maria [3 ]
Srisailam, Sampath [1 ,2 ]
Karra, Murthy [1 ,2 ]
Benchimol, Sam [4 ]
Arrowsmith, Cheryl H. [1 ,2 ]
机构
[1] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada
[3] Linkoping Univ, IFM, S-58183 Linkoping, Sweden
[4] York Univ, Dept Biol, N York, ON M3J 1P3, Canada
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nsmb.1521
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pirh2 (p53-induced RING-H2 domain protein; also known as Rchy1) is an E3 ubiquitin ligase involved in a negative-feedback loop with p53. Using NMR spectroscopy, we show that Pirh2 is a unique cysteine-rich protein comprising three modular domains. The protein binds nine zinc ions using a variety of zinc coordination schemes, including a RING domain and a left-handed beta-spiral in which three zinc ions align three consecutive small beta-sheets in an interleaved fashion. We show that Pirh2-p53 interaction is dependent on the C-terminal zinc binding module of Pirh2, which binds to the tetramerization domain of p53. As a result, Pirh2 preferentially ubiquitylates the tetrameric form of p53 in vitro and in vivo, suggesting that Pirh2 regulates protein turnover of the transcriptionally active form of p53.
引用
收藏
页码:1334 / 1342
页数:9
相关论文
共 50 条
  • [21] A molecular glue for P53
    Hai-Kun Liu
    Medicine Plus, 2024, 1 (02) : 24 - 25
  • [22] WWP2 ameliorates acute kidney injury by mediating p53 ubiquitylation and degradation
    Che, Hong
    He, Weilai
    Feng, Junbo
    Dong, Wenpeng
    Liu, Shandong
    Chen, Tao
    Ge, Shenglin
    Zhou, Jun
    Liang, Chaozhao
    CELL BIOCHEMISTRY AND FUNCTION, 2020, 38 (06) : 695 - 701
  • [23] IRTKS suppresses p53 activity through promoting MDM2 mediated p53 monoubiquitination
    Zhang, Xin
    Wang, Kesheng
    Sheng, Hailian
    Li, Tingting
    Chen, Gang
    Chen, Fei
    Wang, Qinwan
    Cheng, Zhihong
    Wang, Zhiqin
    Han, Zeguang
    CANCER RESEARCH, 2010, 70
  • [24] Molecular Basis for Modulation of the p53 Target Selectivity by KLF4
    Brandt, Tobias
    Townsley, Fiona M.
    Teufel, Daniel P.
    Freund, Stefan M. V.
    Veprintsev, Dmitry B.
    PLOS ONE, 2012, 7 (10):
  • [25] Targeting Taurine Transporter (TauT) for Cancer Immunotherapy of p53 Mutation Mediated Cancers - Molecular Basis and Preclinical Implication
    Han, Xiaobin
    TAURINE 11, 2019, 1155 : 543 - 553
  • [26] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk
    Roberto Salvi
    Manuela Argentini
    Christine Dureuil
    Isabelle Delumeau
    Joseph Abecassis
    Laurent Debussche
    Bohdan Wasylyk
    Oncogene, 1999, 18 : 1921 - 1934
  • [27] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Wasylyk, C
    Salvi, R
    Argentini, M
    Dureuil, C
    Delumeau, I
    Abecassis, J
    Debussche, L
    Wasylyk, B
    ONCOGENE, 1999, 18 (11) : 1921 - 1934
  • [28] A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
    Bernal, Federico
    Wade, Mark
    Godes, Marina
    Davis, Tina N.
    Whitehead, David G.
    Kung, Andrew L.
    Wahl, Geoffrey M.
    Walensky, Loren D.
    CANCER CELL, 2010, 18 (05) : 411 - 422
  • [29] Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53
    Lan Wang
    Guifen He
    Pingzhao Zhang
    Xiang Wang
    Mei Jiang
    Long Yu
    Molecular Biology Reports, 2011, 38 : 229 - 236
  • [30] The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53
    Higashitsuji, H
    Higashitsuji, H
    Itoh, K
    Sakurai, T
    Nagao, T
    Sumitomo, H
    Masuda, T
    Dawson, S
    Shimada, Y
    Mayer, RJ
    Fujita, J
    CANCER CELL, 2005, 8 (01) : 75 - 87